Year |
Citation |
Score |
2011 |
Gabet Y, Noh T, Lee C, Frenkel B. Developmentally regulated inhibition of cell cycle progression by glucocorticoids through repression of cyclin A transcription in primary osteoblast cultures. Journal of Cellular Physiology. 226: 991-8. PMID 20857405 DOI: 10.1002/Jcp.22412 |
0.695 |
|
2009 |
Noh T, Gabet Y, Cogan J, Shi Y, Tank A, Sasaki T, Criswell B, Dixon A, Lee C, Tam J, Kohler T, Segev E, Kockeritz L, Woodgett J, Müller R, et al. Lef1 haploinsufficient mice display a low turnover and low bone mass phenotype in a gender- and age-specific manner. Plos One. 4: e5438. PMID 19412553 DOI: 10.1371/Journal.Pone.0005438 |
0.702 |
|
2008 |
Luppen CA, Chandler RL, Noh T, Mortlock DP, Frenkel B. BMP-2 vs. BMP-4 expression and activity in glucocorticoid-arrested MC3T3-E1 osteoblasts: Smad signaling, not alkaline phosphatase activity, predicts rescue of mineralization. Growth Factors (Chur, Switzerland). 26: 226-37. PMID 19021035 DOI: 10.1080/08977190802277880 |
0.682 |
|
2008 |
Leclerc N, Noh T, Cogan J, Samarawickrama DB, Smith E, Frenkel B. Opposing effects of glucocorticoids and Wnt signaling on Krox20 and mineral deposition in osteoblast cultures. Journal of Cellular Biochemistry. 103: 1938-51. PMID 17973254 DOI: 10.1002/Jcb.21587 |
0.766 |
|
2008 |
Gabet Y, Noh T, Cogan J, Tank A, Sasaki T, Criswell B, Dixon A, Tam J, Kohler T, Regev E, Kockeritz L, Woodgett J, Müller R, Chai Y, Smith E, et al. Gender-specific control of peak bone mass by the Wnt pathway: Androgen signaling protects against lef1 haploinsufficiency-induced bone loss Bone. 42: S50. DOI: 10.1016/J.Bone.2007.12.085 |
0.701 |
|
2005 |
Miguel SM, Namdar-Attar M, Noh T, Frenkel B, Bab I. ERK1/2-activated de novo Mapkapk2 synthesis is essential for osteogenic growth peptide mitogenic signaling in osteoblastic cells. The Journal of Biological Chemistry. 280: 37495-502. PMID 16150701 DOI: 10.1074/Jbc.M503861200 |
0.691 |
|
2005 |
Leclerc N, Noh T, Khokhar A, Smith E, Frenkel B. Glucocorticoids inhibit osteocalcin transcription in osteoblasts by suppressing Egr2/Krox20-binding enhancer. Arthritis and Rheumatism. 52: 929-39. PMID 15751078 DOI: 10.1002/Art.20872 |
0.739 |
|
2005 |
Smith E, Meyerrose TE, Kohler T, Namdar-Attar M, Bab N, Lahat O, Noh T, Li J, Karaman MW, Hacia JG, Chen TT, Nolta JA, Müller R, Bab I, Frenkel B. Leaky ribosomal scanning in mammalian genomes: significance of histone H4 alternative translation in vivo. Nucleic Acids Research. 33: 1298-308. PMID 15741183 DOI: 10.1093/Nar/Gki248 |
0.598 |
|
2003 |
Luppen CA, Leclerc N, Noh T, Barski A, Khokhar A, Boskey AL, Smith E, Frenkel B. Brief bone morphogenetic protein 2 treatment of glucocorticoid-inhibited MC3T3-E1 osteoblasts rescues commitment-associated cell cycle and mineralization without alteration of Runx2. The Journal of Biological Chemistry. 278: 44995-5003. PMID 12933820 DOI: 10.1074/Jbc.M306730200 |
0.641 |
|
Show low-probability matches. |